Mikhail Blagosklonny, an oncologist at Roswell Park Cancer Institute, has found what many refer to as a magic formula for anti-aging. This formula is known as the rapamycin analog, an analog that could powerfully impact both cancer and anti-aging. This particular analog, known as Everolimus, is the one to watch for the miracle of anti-aging. Additionally, the anti-aging is an extra benefit with a stronger immune system being the main focus for those who are considered to be elderly. These facts are essential to the understanding of research and how the future looks for the elderly as they face immortality. This research is so forthcoming, that it causes other doctors to consider how geriatric care will fare when aging has been slowed down so dramatically.
There are numerous ways in which Blagosklonny has contributed to the field of medicine, and furthermore, the research he has conducted regarding the rapaymycin analog now makes him the foremost expert in this particular area of oncology. Additionally, this research has also been submitted into his peer reviewed journal, Oncotarget, sharing this research and information with other physicians that work in oncology as well as closely related specialties. As the department head of Cell Stress Biology at Roswell Institute for Cancer, this research will ultimately extend to see how this analog or similar analogs in other life forms can slow down aging and improve the overall health of any animal or mammal.
As the research continues, there is a search for whether or not rapamycin directly impacts cancer. There have already been cases in which this has been proven to be true both in young and old animals. Their traits and phenotypes have all been considered when considering their lifetime expectancy as well as their ability to ward off disease and much more. This has now led to the FDA approval of Rapamycin, and it is already being actively used in veterinary offices around the world. Studies have included both short-term and long-term effects of the use of this drug. Visit ResearchGate to know more about Mikhail’s latest work.
Mikhail Blagosklonny has been deemed as one of the foremost researchers and experts in the field oncology, and he has been regarded as the source for information as it pertains to current and future research on rapamycin and other ways in which it can be used.